Novel behavioural characteristics of female APPSwe/PS1δE9 double transgenic mice

Behavioural Brain Research

Volumn 260, Issue , 2014, Pages 111-118

  Cheng, David ^a,b   Low, Jac Kee ^a,c   Logge, Warren ^a,c   Garner, Brett ^d   Karl, Tim ^a,b,c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Alzheimer's disease; Behaviour; Cheeseboard; Sensorimotor gating; Social recognition memory

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; LEARNING DISORDER; LOCOMOTION; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OBJECT RELATION; PATTERN RECOGNITION; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; SENSORY GATING; SOCIAL RECOGNITION TEST; TASK PERFORMANCE;

ALZHEIMER'S DISEASE; BEHAVIOUR; CHEESEBOARD; SENSORIMOTOR GATING; SOCIAL RECOGNITION MEMORY; TRANSGENIC APP(SWE)/PS1ΔE9 MICE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANXIETY; COGNITION; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PRESENILIN-1; RECOGNITION (PSYCHOLOGY); SENSORY GATING; SOCIAL BEHAVIOR; SPACE PERCEPTION; TASK PERFORMANCE AND ANALYSIS;

EID: 84890711113     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.11.046     Document Type: Article

References (59)

1. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
2. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982, 139:1136-1139.
3. Chung J.A., Cummings J.L. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment. Neurol Clin 2000, 18:829-846.
4. Kamboh M.I. Molecular genetics of late-onset Alzheimer's disease. Ann Human Genet 2004, 68:381-404.
5. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008, 9:532-544.
6. Alonso Vilatela M.E., Lopez-Lopez M., Yescas-Gomez P. Genetics of Alzheimer's disease. Arch Med Res 2012, 43:622-631.
7. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004, 13:159-170.
8. Jankowsky J.L., Slunt H.H., Gonzales V., Jenkins N.A., Copeland N.G., Borchelt D.R. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 2004, 25:885-892.
9. Wang J., Tanila H., Puolivali J., Kadish I., van Groen T. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis 2003, 14:318-327.
10. Machova E., Jakubik J., Michal P., Oksman M., Iivonen H., Tanila H., et al. Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice. Neurobiol Aging 2008, 29:368-378.
11. Machova E., Rudajev V., Smyckova H., Koivisto H., Tanila H., Dolezal V. Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice. Neurobiol Dis 2010, 38:27-35.
12. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997, 19:939-945.
13. Cheng D., Logge W., Low J.K., Garner B., Karl T. Novel behavioural characteristics of the APP(Swe)/PS1DeltaE9 transgenic mouse model of Alzheimer's Disease. Behav Brain Res 2013, 245:120-127.
14. Gallagher J.J., Minogue A.M., Lynch M.A. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Abeta accumulation and microglial activation. Neurodegener Dis 2013, 11:33-41.
15. Butovsky O., Koronyo-Hamaoui M., Kunis G., Ophir E., Landa G., Cohen H., et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA 2006, 103:11784-11789.
16. Donkin J.J., Stukas S., Hirsch-Reinshagen V., Namjoshi D., Wilkinson A., May S., et al. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice. J Biol Chem 2010, 285:34144-34154.
17. Jardanhazi-Kurutz D., Kummer M.P., Terwel D., Vogel K., Dyrks T., Thiele A., et al. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits. Neurochem Int 2010, 57:375-382.
18. Timmer N.M., van Dijk L., van der Zee C.E., Kiliaan A., de Waal R.M., Verbeek M.M. Enoxaparin treatment administered at both early and late stages of amyloid beta deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Abeta levels. Neurobiol Dis 2010, 40:340-347.
19. Stover K.R., Brown R.E. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav Brain Res 2012, 231:75-85.
20. Hurst J.L., West R.S. Taming anxiety in laboratory mice. Nat Methods 2010, 7:825-826.
21. Reiserer R.S., Harrison F.E., Syverud D.C., McDonald M.P. Impaired spatial learning in the APPSwe+PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 2007, 6:54-65.
22. Lalonde R., Kim H.D., Fukuchi K. Exploratory activity, anxiety, and motor coordination in bigenic APPswe+PS1/DeltaE9 mice. Neurosci Lett 2004, 369:156-161.
23. Llano Lopez L., Hauser J., Feldon J., Gargiulo P.A., Yee B.K. Evaluating spatial memory function in mice: a within-subjects comparison between the water maze test and its adaptation to dry land. Behav Brain Res 2010, 209:85-92.
24. Gerlai R. Behavioral tests of hippocampal function: simple paradigms complex problems. Behav Brain Res 2001, 125:269-277.
25. Iivonen H., Nurminen L., Harri M., Tanila H., Puolivali J. Hypothermia in mice tested in Morris water maze. Behav Brain Res 2003, 141:207-213.
26. Lipp H.P., Wolfer D.P. Genetically modified mice and cognition. Curr Opin Neurobiol 1998, 8:272-280.
27. Mizunoya W., Oyaizu S., Hirayama A., Fushiki T. Effects of physical fatigue in mice on learning performance in a water maze. Biosci Biotechnol Biochem 2004, 68:827-834.
28. Wolfer D.P., Stagljar-Bozicevic M., Errington M.L., Lipp H.P. Spatial memory learning in transgenic mice: fact or artifact. News Physiol Sci 1998, 13:118-123.
29. Karl T., Bhatia S., Cheng D., Kim W.S., Garner B. Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behav Brain Res 2012, 228:392-397.
30. Kim W.S., Li H., Ruberu K., Chan S., Elliott D.A., Low J.K., et al. Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease. J Neurosci 2013, 33:4387-4394.
31. Pillay N.S., Kellaway L.A., Kotwal G.J. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model. Behav Brain Res 2008, 192:173-177.
32. Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 2001, 17:157-165.
33. Kopp C. Locomotor activity rhythm in inbred strains of mice: implications for behavioural studies. Behav Brain Res 2001, 125:93-96.
34. Karl T., Duffy L., Scimone A., Harvey R.P., Schofield P.R. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav 2007, 6:677-687.
35. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 1955, 48:254-260.
36. Montgomery K.C., Monkman J.A. The relation between fear and exploratory behavior. J Comp Physiol Psychol 1955, 48:132-136.
37. Karl T., Duffy L., Herzog H. Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci 2008, 28:173-180.
38. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 2007, 31:673-704.
39. Logge W., Cheng D., Chesworth R., Bhatia S., Garner B., Kim W.S., et al. Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases. PLoS One 2012, 7:e45959.
40. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302.
41. Chesworth R., Downey L., Logge W., Killcross S., Karl T. Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav Brain Res 2012, 226:218-223.
42. Duffy L., Cappas E., Lai D., Boucher A.A., Karl T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 2010, 170:800-807.
43. Wang H., He J., Zhang R., Zhu S., Wang J., Kong L., et al. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease. Behav Brain Res 2012, 233:237-243.
44. van den Buuse M., Wischhof L., Lee R.X., Martin S., Karl T. Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int J Neuropsychopharmacol 2009, 12:1383-1393.
45. Hooijmans C.R., Van der Zee C.E., Dederen P.J., Brouwer K.M., Reijmer Y.D., van Groen T., et al. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis 2009, 33:482-498.
46. Post A.M., Weyers P., Holzer P., Painsipp E., Pauli P., Wultsch T., et al. Gene-environment interaction influences anxiety-like behavior in ethologically based mouse models. Behav Brain Res 2011, 218:99-105.
47. Kulkarni A.P., Pillay N.S., Kellaway L.A., Kotwal G.J. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test. Biogerontology 2008, 9:405-420.
48. Ragozzino M.E., Wilcox C., Raso M., Kesner R.P. Involvement of rodent prefrontal cortex subregions in strategy switching. Behav Neurosci 1999, 113:32-41.
49. Bannerman D.M., Yee B.K., Good M.A., Heupel M.J., Iversen S.D., Rawlins J.N. Double dissociation of function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav Neurosci 1999, 113:1170-1188.
50. Kim J.H., Anwyl R., Suh Y.H., Djamgoz M.B., Rowan M.J. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci 2001, 21:1327-1333.
51. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
52. Bonardi C., de Pulford F., Jennings D., Pardon M.C. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease. Behav Brain Res 2011, 222:89-97.
53. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 2004, 114:1624-1634.
54. Wesson D.W., Keller M., Douhard Q., Baum M.J., Bakker J. Enhanced urinary odor discrimination in female aromatase knockout (ArKO) mice. Horm Behav 2006, 49:580-586.
55. O'Tuathaigh C.M., Babovic D., O'Sullivan G.J., Clifford J.J., Tighe O., Croke D.T., et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 2007, 147:18-27.
56. Fairless A.H., Dow H.C., Kreibich A.S., Torre M., Kuruvilla M., Gordon E., et al. Sociability and brain development in BALB/cJ and C57BL/6J mice. Behav Brain Res 2012, 228:299-310.
57. Moy S.S., Nadler J.J., Young N.B., Nonneman R.J., Segall S.K., Andrade G.M., et al. Social approach and repetitive behavior in eleven inbred mouse strains. Behav Brain Res 2008, 191:118-129.
58. Jessen F., Kucharski C., Fries T., Papassotiropoulos A., Hoenig K., Maier W., et al. Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease. Am J Psychiatry 2001, 158:1319-1321.
59. Karl T., Burne T.H., Van den Buuse M., Chesworth R. Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit. Behav Brain Res 2011, 223:336-341.